The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.

Columnist Candace Semien considers the rules, both written and unspoken, about how to maintain a healthy patient-doctor relationship.

Columnist Candace Semien is putting her body on a performance improvement plan so that she handles the Job of Life as best she can.

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and other organs.

The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

Columnist Marisa Zeppieri shares insight she gained, before she got married, about chronic illness and dating.

Caribou's CB-010 CAR T-cell therapy for SLE that's resistant to available treatments has been granted fast track designation by the U.S. FDA.

Patient screening has begun in the Ntrust-1 clinical trial of NKX019, a potential CAR cell therapy for treatment-resistant lupus nephritis.

A recent beach adventure prompts columnist Candace Semien to reflect on the value of doing something for the first time.